Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta
- 1 September 2002
- journal article
- case report
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 74 (3) , 910-912
- https://doi.org/10.1016/s0003-4975(02)03700-1
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- An Effective Treatment of Severe Intractable Bleeding After Valve Repair by One Single Dose of Activated Recombinant Factor VIIAnesthesia & Analgesia, 2001
- The Factor VII-Platelet Interplay: Effectiveness of Recombinant Factor VIIa in the Treatment of Bleeding in Severe ThrombocytopathiaSeminars in Thrombosis and Hemostasis, 2000
- Comparison of the factor VII:C clot analysis and a modified activated factor VII analysis for monitoring factor VII activity in patients treated with recombinant activated factor VII (NovoSeven®)Blood Coagulation & Fibrinolysis, 2000
- Osteogenesis imperfecta and cardiovascular diseasesThe Annals of Thoracic Surgery, 1995
- Cardiovascular involvement in osteogenesis imperfecta.Circulation, 1986